Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| renal beta-intercalated cell | 4 studies | 94% ± 4% | |
| renal alpha-intercalated cell | 3 studies | 41% ± 12% |
Insufficient scRNA-seq data for expression of SLC4A9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 5186.69 | 89 / 89 | 10% | 1.90 | 92 / 901 |
| thymus | 99% | 45.30 | 644 / 653 | 1% | 0.04 | 5 / 605 |
| brain | 98% | 44.23 | 2588 / 2642 | 1% | 0.03 | 9 / 705 |
| lung | 92% | 21.71 | 532 / 578 | 2% | 0.04 | 24 / 1155 |
| adipose | 82% | 20.09 | 992 / 1204 | 0% | 0 | 0 / 0 |
| prostate | 80% | 24.23 | 197 / 245 | 1% | 0.01 | 4 / 502 |
| pancreas | 74% | 14.56 | 242 / 328 | 1% | 0.02 | 2 / 178 |
| esophagus | 67% | 11.50 | 974 / 1445 | 7% | 0.16 | 12 / 183 |
| heart | 69% | 11.01 | 593 / 861 | 0% | 0 | 0 / 0 |
| spleen | 68% | 10.06 | 165 / 241 | 0% | 0 | 0 / 0 |
| stomach | 62% | 7.04 | 224 / 359 | 4% | 0.07 | 11 / 286 |
| peripheral blood | 65% | 19.62 | 602 / 929 | 0% | 0 | 0 / 0 |
| breast | 61% | 7.92 | 280 / 459 | 0% | 0.01 | 5 / 1118 |
| bladder | 57% | 9.33 | 12 / 21 | 4% | 0.07 | 19 / 504 |
| intestine | 55% | 6.65 | 528 / 966 | 1% | 0.02 | 5 / 527 |
| uterus | 49% | 5.91 | 84 / 170 | 1% | 0.02 | 5 / 459 |
| skin | 48% | 6.51 | 870 / 1809 | 0% | 0 | 0 / 472 |
| blood vessel | 48% | 6.07 | 642 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 47% | 5.50 | 120 / 258 | 0% | 0.01 | 1 / 230 |
| muscle | 46% | 6.56 | 366 / 803 | 0% | 0 | 0 / 0 |
| ovary | 20% | 2.19 | 36 / 180 | 2% | 0.03 | 8 / 430 |
| liver | 12% | 0.96 | 26 / 226 | 0% | 0.00 | 1 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.17 | 2 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.05 | 1 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0046541 | Biological process | saliva secretion |
| GO_0051453 | Biological process | regulation of intracellular pH |
| GO_0015701 | Biological process | bicarbonate transport |
| GO_1902476 | Biological process | chloride transmembrane transport |
| GO_0035725 | Biological process | sodium ion transmembrane transport |
| GO_0055085 | Biological process | transmembrane transport |
| GO_0045177 | Cellular component | apical part of cell |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016323 | Cellular component | basolateral plasma membrane |
| GO_0140900 | Molecular function | chloride:bicarbonate antiporter activity |
| GO_0140892 | Molecular function | sodium,bicarbonate:chloride antiporter activity |
| GO_0008510 | Molecular function | sodium:bicarbonate symporter activity |
| Gene name | SLC4A9 |
| Protein name | Anion exchange protein 4 (AE 4) (Anion exchanger 4) (Sodium bicarbonate cotransporter 5) (Solute carrier family 4 member 9) |
| Synonyms | AE4 SBC5 |
| Description | FUNCTION: Electroneutral Cl(-)/HCO3(-) antiporter that favors chloride ion entry and efflux of hydrogencarbonate and sodium ion across the basolateral membrane and may participate in salivary secretion . Also mediates Cl(-)/HCO3(-) exchange activity in the presence of K(+) as well as Cs(+), Li(+), and Rb(+) (By similarity). Does not contribute to Cl(-)/HCO3(-) exchanger in the apical membrane of the upper villous epithelium (By similarity). . |
| Accessions | ENST00000506757.7 [Q96Q91-3] ENST00000432095.6 [Q96Q91-2] ENST00000507527.1 [Q96Q91-1] ENST00000506545.5 [Q96Q91-4] Q96Q91 |